Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BCAX
Stock Latest News
The Fly
Bicara Therapeutics initiated with a Neutral at Mizuho
12d ago
BCAX
Premium
Ratings
Promising Efficacy and Investment Potential for Bicara Therapeutics’ FICERA in Combination with Keytruda
21d ago
BCAX
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today, 12/8/2025, According to Top Analysts
21d ago
BCAX
HASI
Premium
Company Announcements
Bicara Therapeutics Reports Promising Phase 1b Data
21d ago
8K
BCAX
Premium
Ratings
Buy Rating for Bicara Therapeutics Inc. Driven by Promising Clinical Data and Strategic Valuation
21d ago
BCAX
Premium
Ratings
Promising Phase 1/1b Results and Future Prospects Boost Bicara Therapeutics’ Buy Rating
21d ago
BCAX
Premium
The Fly
Bicara announces preliminary data from Phase 1b cohort of ficerafusp alfa
22d ago
BCAX
Premium
Ratings
Positive Outlook for Bicara Therapeutics: Promising Phase 1b Results and Safety Profile Support Buy Rating
27d ago
BCAX
Premium
Ratings
Buy Rating for Bicara Therapeutics Driven by Promising Efficacy and Safety of FICERA in ESMO Asia Abstract
29d ago
BCAX
Premium
Pre-Earnings
Bicara Therapeutics Inc. (BCAX) Q3 Earnings Cheat Sheet
1M ago
BCAX
Premium
Ratings
Promising Drug Pipeline and Upcoming Trial Data Support Buy Rating for Bicara Therapeutics
2M ago
BCAX
Premium
The Fly
Bicara Therapeutics reports Q3 EPS (67c), consensus (53c)
2M ago
BCAX
Premium
Company Announcements
Bicara Therapeutics’ FORTIFI-HN01 Study: A Promising Step in Cancer Treatment
2M ago
BCAX
Premium
Company Announcements
Bicara Therapeutics’ Innovative Approach to EGFR-Driven Tumors: A Clinical Study Update
2M ago
BCAX
Premium
Ratings
Bicara Therapeutics: Strategic Advantages and Favorable Safety Profile Drive Buy Rating
2M ago
BCAX
Premium
The Fly
Bicara sinks after J&J reports head and neck cancer data
2M ago
JNJ
BCAX
Premium
The Fly
Bicara Therapeutics management to meet with Cantor Fitzgerald
2M ago
BCAX
Premium
The Fly
Bicara Therapeutics announces ficerafusp alfa granted BTD by U.S. FDA
3M ago
BCAX
Premium
The Fly
Bicara Therapeutics files $400M mixed securities shelf
3M ago
BCAX
Premium
Ratings
Promising Market Opportunity for Bicara Therapeutics in HPV-Negative Head & Neck Cancer Warrants Buy Rating
3M ago
BCAX
Premium
Ratings
Optimistic Buy Rating for Bicara Therapeutics: Superior Clinical Benefits and Valuation Upside
3M ago
BCAX
Premium
The Fly
Bicara Therapeutics initiated with a Buy at JonesResearch
4M ago
BCAX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
